250 related articles for article (PubMed ID: 31423947)
1. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
[TBL] [Abstract][Full Text] [Related]
2. Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review.
Snyder M; Pasikhova Y; Baluch A
Open Forum Infect Dis; 2017; 4(4):ofx226. PubMed ID: 29255727
[TBL] [Abstract][Full Text] [Related]
3. De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia.
Rearigh L; Stohs E; Freifeld A; Zimmer A
Ann Hematol; 2020 Aug; 99(8):1917-1924. PubMed ID: 32556455
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
Ly WJ; Brown EE; Pedretti Z; Auten J; Wilson WS
J Oncol Pharm Pract; 2023 Mar; 29(2):305-310. PubMed ID: 34927495
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
Kroll AL; Corrigan PA; Patel S; Hawks KG
J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
[TBL] [Abstract][Full Text] [Related]
6. De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period.
Gustinetti G; Raiola AM; Varaldo R; Galaverna F; Gualandi F; Del Bono V; Bacigalupo A; Angelucci E; Viscoli C; Mikulska M
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1721-1726. PubMed ID: 29578073
[TBL] [Abstract][Full Text] [Related]
7. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
Kaya AH; Tekgündüz E; Duygu F; Koca D; Bekdemir F; Batgi H; Ulu Uncu B; Yiğenoğlu TN; Dal MS; Çakar Kızıl M; Altuntaş F
Balkan Med J; 2017 Apr; 34(2):132-139. PubMed ID: 28418340
[TBL] [Abstract][Full Text] [Related]
8. Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count-driven approach.
Horowitz JG; Gawrys GW; Lee GC; Ramirez BA; Elledge CM; Shaughnessy PJ
Transpl Infect Dis; 2021 Aug; 23(4):e13689. PubMed ID: 34255395
[TBL] [Abstract][Full Text] [Related]
9. Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation.
Schmidt-Hieber M; Teschner D; Maschmeyer G; Schalk E
Expert Rev Anti Infect Ther; 2019 Dec; 17(12):983-995. PubMed ID: 30686067
[No Abstract] [Full Text] [Related]
10. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
Jing Y; Li J; Yuan L; Zhao X; Wang Q; Yu L; Zhou D; Huang W
Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?
Butters C; Thursky K; Hanna DT; Cole T; Davidson A; Buttery J; Haeusler G
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):267-279. PubMed ID: 36694289
[TBL] [Abstract][Full Text] [Related]
13. Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized Trial.
Ram R; Amit O; Adler A; Bar-On Y; Beyar-Katz O; Avivi I; Shasha D; Ben-Ami R
Transplant Cell Ther; 2023 Nov; 29(11):708.e1-708.e8. PubMed ID: 37591446
[TBL] [Abstract][Full Text] [Related]
14. Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature.
Pillinger KE; Bouchard J; Withers ST; Mediwala K; McGee EU; Gibson GM; Bland CM; Bookstaver PB
Ann Pharmacother; 2020 Jun; 54(6):594-610. PubMed ID: 31771337
[No Abstract] [Full Text] [Related]
15. Outcomes Associated with De-escalation of Antibiotics to Target Positive Cultures when Treating Febrile Neutropenia.
Rainess R; Campbell P; Santamala J; Kubin CJ; Mehta M
J Pharm Pract; 2024 Apr; 37(2):301-306. PubMed ID: 36201023
[No Abstract] [Full Text] [Related]
16. Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
Aguilar-Guisado M; Espigado I; Martín-Peña A; Gudiol C; Royo-Cebrecos C; Falantes J; Vázquez-López L; Montero MI; Rosso-Fernández C; de la Luz Martino M; Parody R; González-Campos J; Garzón-López S; Calderón-Cabrera C; Barba P; Rodríguez N; Rovira M; Montero-Mateos E; Carratalá J; Pérez-Simón JA; Cisneros JM
Lancet Haematol; 2017 Dec; 4(12):e573-e583. PubMed ID: 29153975
[TBL] [Abstract][Full Text] [Related]
17. Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.
Parta M; Cuellar-Rodriguez J; Gea-Banacloche J; Qin J; Kelly C; Zerbe CS; Holland SM; Malech HL; Kang EM
Transpl Infect Dis; 2022 Apr; 24(2):e13815. PubMed ID: 35191140
[TBL] [Abstract][Full Text] [Related]
18. Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies.
Stohs EJ; Abbas A; Freifeld A
Transpl Infect Dis; 2024 Apr; 26(2):e14236. PubMed ID: 38349035
[TBL] [Abstract][Full Text] [Related]
19. Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation.
Clemmons AB; Gandhi AS; Albrecht B; Jacobson S; Pantin J
J Oncol Pharm Pract; 2019 Mar; 25(2):326-332. PubMed ID: 29059026
[TBL] [Abstract][Full Text] [Related]
20. Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
Rönkkö R; Juutilainen A; Koivula I; Vänskä M; Nousiainen T; Jantunen E; Hämäläinen S
Infect Dis (Lond); 2018 Jun; 50(6):436-442. PubMed ID: 29303041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
